7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Irritable bowel syndrome (IBS) is a common condition characterised by abdominal pain, bloating, and poor quality of life. IBS might be caused by a gut dysbiosis. We aimed to compare faecal microbiota transplantation (FMT) with placebo in patients with IBS.

          Related collections

          Author and article information

          Journal
          The Lancet Gastroenterology & Hepatology
          The Lancet Gastroenterology & Hepatology
          Elsevier BV
          24681253
          January 2018
          January 2018
          : 3
          : 1
          : 17-24
          Article
          10.1016/S2468-1253(17)30338-2
          29100842
          a05d2f82-8ab2-49c6-b17e-96b1615d7e64
          © 2018

          http://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article